Persistent URL of this record https://hdl.handle.net/1887/98365
In Collections
This item can be found in the following collections:
Preclinical Safety and Efficacy of Human CD34(+) Cells Transduced With Lentiviral Vector for the Treatment of Wiskott-Aldrich Syndrome
- All authors
- Scaramuzza, S.; Biasco, L.; Ripamonti, A.; Castiello, M.C.; Loperfido, M.; Draghici, E.; Hernandez, R.J.; Benedicenti, F.; Radrizzani, M.; Salomoni, M.; Ranzani, M.; Bartholomae, C.C.; Vicenzi, E.; Finocchi, A.; Bredius, R.; Bosticardo, M.; Schmidt, M.; Kalle, C. von; Montini, E.; Biffi, A.; Roncarolo, M.G.; Naldini, L.; Villa, A.; Aiuti, A.
- Date
- 2013-01-31
- Journal
- Molecular Therapy
- Volume
- 21
- Issue
- 1
- Pages
- 175 - 184